Albumedix Media News & Events Mantell Associates talks with Jonas Skjødt Møller and Gregor Kawaletz

Mantell Associates talks with Jonas Skjødt Møller and Gregor Kawaletz

12 Mar 2021

In a conversation with Alessandro Mantell from Mantell Associates, Jonas Møller and Gregor Kawaletz were happy to join the list of previous podcast guests, sharing their experience of COVID-19 and how it has been adapting to life and business during the global pandemic. Words like 'different' and 'challenging' definitely come up when considering this past year, but also how rewarding it has been to see the life science industry come together and collaborative. This podcast episode delves into the importance of flexibility and agility in business during COVID-19 and how a business can either fight for the old ways or embrace the situation of having to build new.

Make sure you head on over to our Spotify Channel to listen to our first episode. 

CONTACT

Albumedix Ltd.
Mabel Street
The Meadows
Nottingham
NG2 3ED, United Kingdom
Tel: +44 115 9553379
info@albumedix.com

 

Albumedix - Dedicated to Better Health

Albumedix is a science-driven, biotechnology company focused on enabling the creation of superior biopharmaceuticals utilizing our albumin-based drug enhancing technologies. We partner with excellence to improve therapies for people with serious diseases. We are proud to be recognized as the world leader in recombinant human albumin with products and technologies used in clinical and marketed drugs by pharmaceutical companies worldwide. Headquartered in Nottingham, England with ~100 people all committed to improving patient quality of life. We are just as passionate about albumin and albumin-enabled therapies today as we were when we started 30 years ago.

 

Privacy | Cookies | Patent Portfolio

ALBUMEDIX, the ALBUMEDIX LOGO, DEDICATED TO BETTER HEALTH and marks such as RECOMBUMIN and VELTIS are trademarks of Albumedix. Albumedix© Copyright 2018

FOLLOW US